<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04680286</url>
  </required_header>
  <id_info>
    <org_study_id>23956082</org_study_id>
    <secondary_id>2020-002945-41</secondary_id>
    <nct_id>NCT04680286</nct_id>
  </id_info>
  <brief_title>Intraoperative Methadone in Children Undergoing Surgery</brief_title>
  <acronym>METACEBO</acronym>
  <official_title>The Use of Intraoperative Methadone in Children Undergoing Open Urological Surgery: a Randomized, Double-blind Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective double-blind, randomized controlled trial investigating the effect of a&#xD;
      single-dose of intraoperative methadone on postoperative pain and opioid consumption in 96&#xD;
      children undergoing open urological surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Treatment of postoperative pain is a challenge in younger children undergoing outpatient&#xD;
      surgery. After discharge parents must assess pain intensity and administer analgesics,&#xD;
      including opioids, as per needed. It has been shown that parents often hesitate to administer&#xD;
      analgesics. The result is unrelieved pain that negatively affects the whole family and&#xD;
      increases the risk of unscheduled contacts with healthcare professionals.&#xD;
&#xD;
      In children, methadone has shown a half-life of 19,2 +/-13,6 hours. Regarding outpatient&#xD;
      surgery, methadone is an opioid with unique pharmalogical properties that may be&#xD;
      advantageous. A single-dose of this long acting opioid administered perioperatively could&#xD;
      provide a stable analgesia and potentially reduce the need for shorter-acting opioids in the&#xD;
      PACU and at home.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 16, 2020</start_date>
  <completion_date type="Anticipated">February 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Randomisation and study medication will be handled by the hospital pharmacy. All research team members, caregiving clinicians and enrolled patients will be blinded to the study allocation arms and the randomisation list will be concealed until all statistical analyses are made.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Patients consumption of analgesics in the PACU.</measure>
    <time_frame>3 hours</time_frame>
    <description>Within the first 3 hours from extubation (or until discharge from PACU, if discharged before 3 hours).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain intensity (highest score)</measure>
    <time_frame>3 hours</time_frame>
    <description>FLACC-score - Face, Legs, Activity, Cry og Consolability, 0-10, where 10 is the highest pain score. Within the first 3 hours from extubation (or until discharge from PACU, if discharged before 3 hours)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Readiness to discharge</measure>
    <time_frame>6 hours</time_frame>
    <description>Time for readiness to discharge from PACU assessed by PACU nurse.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients need of supplemental oxygen in PACU</measure>
    <time_frame>3 hours</time_frame>
    <description>Need of supplemental oxygen within the first 3 hours after extubation,(or until discharge from PACU, if discharged before 3 hours)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Awakenings during the first night after discharge.</measure>
    <time_frame>24 hours</time_frame>
    <description>Parents will answer whether the child have been awake and whether they believe the awakening(s) where due to pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity the first postoperative day</measure>
    <time_frame>48 hours</time_frame>
    <description>Assessed by parents, 3 FLACC-scores - Face, Legs, Activity, Cry og Consolability, 0-10, where 10 is the highest pain score, during the first postoperative day.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic consumption following discharge until evening on the first postoperative day</measure>
    <time_frame>36 hours</time_frame>
    <description>From discharge until 8 PM the first day following surgery. Collected by parents.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unscheduled parental contacts to the hospital</measure>
    <time_frame>4 days</time_frame>
    <description>Parental contacts to hospital regarding pain and/or analgesics until 4 days following surgery.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>FLACC-scores - Face, Legs, Activity, Cry og Consolability, 0-10, where 10 is the highest pain score, at home</measure>
    <time_frame>48 hours</time_frame>
    <description>Parental experience with assessment of the FLACC-score at home following discharge.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Pain, Acute</condition>
  <condition>Pain, Postoperative</condition>
  <condition>Children, Only</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A 5 ml syringe with saline will be prepared and study drug will be administered as intravenous bolus dose (0.1 mg/kg). The study drug will be administered at induction of anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Methadone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A 5 ml syringe with 1 mg/ml of methadone will be prepared and study drug will be administered as intravenous bolus dose (0.1 mg/kg). The study drug will be administered at induction of anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methadone Hydrochloride</intervention_name>
    <description>Single dose, intravenous bolus, 0,1 mg/kg administered at induction of anesthesia.</description>
    <arm_group_label>Methadone</arm_group_label>
    <other_name>Methadone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Single dose, intravenous bolus. Administered as the experimental arm.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Children scheduled for open urological surgery at the Outpatient Clinic at Aarhus&#xD;
        University Hospital.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age =/&gt; 5 years at the date of operation&#xD;
&#xD;
          -  Born preterm (Before gestational age of 37 weeks)&#xD;
&#xD;
          -  Congenital heart disease&#xD;
&#xD;
          -  Previous scrotal surgery&#xD;
&#xD;
          -  Laparoscopic operation&#xD;
&#xD;
          -  American Society of Anaesthesiologists (ASA) physical status lll, IV or V&#xD;
&#xD;
          -  Allergy to study drugs&#xD;
&#xD;
          -  Preoperative daily use of opioids&#xD;
&#xD;
          -  Parents with inability to provide informed consent&#xD;
&#xD;
          -  Severe respiratory insufficiency&#xD;
&#xD;
          -  Acute abdominal pain&#xD;
&#xD;
          -  Severe kidney insufficiency&#xD;
&#xD;
          -  Treatment with rifampicin&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Camilla G Uhrbrand, MD</last_name>
    <phone>23956082</phone>
    <phone_ext>0045</phone_ext>
    <email>camgaa@rm.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lone Nikolajsen, MD, DMSc</last_name>
    <phone>78464317</phone>
    <email>lone.nikolajsen@clin.au.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Camilla G Uhrbrand, MD</last_name>
      <phone>23956082</phone>
      <phone_ext>0045</phone_ext>
      <email>camgaa@rm.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 11, 2020</study_first_submitted>
  <study_first_submitted_qc>December 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 22, 2020</study_first_posted>
  <last_update_submitted>December 17, 2020</last_update_submitted>
  <last_update_submitted_qc>December 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>methadone</keyword>
  <keyword>analgesics</keyword>
  <keyword>opioids</keyword>
  <keyword>postoperative</keyword>
  <keyword>placebo</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methadone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

